600062 华润双鹤
已收盘 08-14 15:00:00
资讯
新帖
简况
利尔化学：华润双鹤已足额缴纳了30%缔约保证金
证券之星 · 16:21
利尔化学：华润双鹤已足额缴纳了30%缔约保证金
华润双鹤(600062.SH)子公司乳酸钠林格冲洗液获得药品注册证书
智通财经 · 08-13 17:07
华润双鹤(600062.SH)子公司乳酸钠林格冲洗液获得药品注册证书
股市必读：华润双鹤新发布《华润双鹤关于控股子公司河南中帅医药科技有限责任公司乙酰唑胺缓释胶囊获得药品注册证书的公告》
证券之星 · 08-13 01:06
股市必读：华润双鹤新发布《华润双鹤关于控股子公司河南中帅医药科技有限责任公司乙酰唑胺缓释胶囊获得药品注册证书的公告》
华润双鹤（600062）披露全资子公司DC7001A胶囊获临床试验批准通知书，8月12日股价上涨0.06%
证券之星 · 08-12 22:17
华润双鹤（600062）披露全资子公司DC7001A胶囊获临床试验批准通知书，8月12日股价上涨0.06%
华润双鹤(600062.SH)子公司乙酰唑胺缓释胶囊获得药品注册证书
智通财经 · 08-11
华润双鹤(600062.SH)子公司乙酰唑胺缓释胶囊获得药品注册证书
华润双鹤：本次并购资金来源于公司自有资金及自筹资金
证券之星 · 08-11
华润双鹤：本次并购资金来源于公司自有资金及自筹资金
华润双鹤：利尔化学为细分领域行业龙头
证券之星 · 08-11
华润双鹤：利尔化学为细分领域行业龙头
股市必读：华润双鹤新发布《华润双鹤关于全资子公司华润双鹤利民药业(济南)有限公司普瑞巴林缓释片完成Ⅲ期临床试验的公告》
证券之星 · 08-10
股市必读：华润双鹤新发布《华润双鹤关于全资子公司华润双鹤利民药业(济南)有限公司普瑞巴林缓释片完成Ⅲ期临床试验的公告》
每周股票复盘：华润双鹤（600062）多款药品拟中选集采
证券之星 · 08-09
每周股票复盘：华润双鹤（600062）多款药品拟中选集采
华润双鹤(600062.SH)子公司普瑞巴林缓释片完成Ⅲ期临床试验
智通财经 · 08-06
华润双鹤(600062.SH)子公司普瑞巴林缓释片完成Ⅲ期临床试验
股市必读：华润双鹤新发布《华润双鹤关于合作方回购八氟丙烷脂质微球注射液相关权益的公告》
证券之星 · 08-06
股市必读：华润双鹤新发布《华润双鹤关于合作方回购八氟丙烷脂质微球注射液相关权益的公告》
华润双鹤（600062）披露合作方回购八氟丙烷脂质微球注射液相关权益的公告，8月4日股价下跌0.06%
证券之星 · 08-04
华润双鹤（600062）披露合作方回购八氟丙烷脂质微球注射液相关权益的公告，8月4日股价下跌0.06%
56.56亿元“A吃A”背后：华润双鹤营收滞涨，利尔化学业绩“过山车”，双重波动下“第二曲线”待考
证券之星 · 08-04
56.56亿元“A吃A”背后：华润双鹤营收滞涨，利尔化学业绩“过山车”，双重波动下“第二曲线”待考
华润双鹤(600062.SH)部分药品拟中选全国药品集中采购
智通财经 · 08-03
华润双鹤(600062.SH)部分药品拟中选全国药品集中采购
股市必读：华润双鹤（600062）7月31日董秘有最新回复
证券之星 · 08-03
股市必读：华润双鹤（600062）7月31日董秘有最新回复
每周股票复盘：华润双鹤（600062）拟56.56亿控股利尔化学
证券之星 · 08-02
每周股票复盘：华润双鹤（600062）拟56.56亿控股利尔化学
华润双鹤：本次现金红利发放日为2026年7月28日
证券之星 · 07-31
华润双鹤：本次现金红利发放日为2026年7月28日
华润双鹤拟现金收购利尔化学23.5%股权 补齐合成生物产业化版图
中国财富通 · 07-31
华润双鹤拟现金收购利尔化学23.5%股权 补齐合成生物产业化版图
华润双鹤（600062）披露拟收购利尔化学23.50%股份事项，7月30日股价下跌3.91%
证券之星 · 07-30
华润双鹤（600062）披露拟收购利尔化学23.50%股份事项，7月30日股价下跌3.91%
华润双鹤入主 利尔化学午收涨停
新京报 · 07-30
华润双鹤入主 利尔化学午收涨停
加载更多
公司概况
公司名称：
华润双鹤药业股份有限公司
所属行业：
医药制造业
上市日期：
1997-05-22
主营业务：
华润双鹤药业股份有限公司的主营业务是慢病业务、专科业务、输液业务、原料药业务。公司的主要产品是缬沙坦、氨氯地平、普瑞巴林、氨苯蝶啶、喷他佐辛、匹伐他汀、素钠、依诺肝素原料、辅酶Q10、S-Na盐。0号、压氏达、穗悦、贝奇灵、糖适平、卜可、冠爽、珂立苏、诺百益、小儿复方氨基酸注射液(19AA-I)、基础输液、BFS等产品获评中国化学制药行业各细分领域优秀产品品牌。
发行价格：
6.69
{"stockData":{"symbol":"600062","market":"SH","secType":"STK","nameCN":"华润双鹤","latestPrice":16,"timestamp":1786690801000,"preClose":16.42,"halted":0,"volume":13916731,"delay":0,"changeRate":-0.0256,"floatShares":1038000000,"shares":1039000000,"eps":1.5648,"marketStatus":"已收盘","change":-0.42,"latestTime":"08-14 15:00:00","open":16.39,"high":16.44,"low":15.97,"amount":225000000,"amplitude":0.0286,"askPrice":16.01,"askSize":53,"bidPrice":16,"bidSize":1021,"shortable":0,"etf":0,"ttmEps":1.5648,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":16.42,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":18.06,"lowLimit":14.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1038582511,"isCdr":false,"pbRate":1.37,"roa":"--","peRate":10.224949,"roe":"4.08%","epsLYR":1.5949,"committee":0.816502,"marketValue":16617000000,"turnoverRate":0.0134,"status":1,"floatMarketCap":16612000000},"requestUrl":"/m/hq/s/600062","defaultTab":"news","newsList":[{"id":"2659112431","title":"利尔化学：华润双鹤已足额缴纳了30%缔约保证金","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659112431?lang=zh_cn&edition=full","pubTime":"2026-08-14 16:21","pubTimestamp":1786695695,"startTime":"0","endTime":"0","summary":"证券之星消息，利尔化学(002258)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问华润双鹤已经交了30%缔约保证金吗？利尔化学回复：尊敬的投资者您好，据向控股股东了解，截止本回复日，协议受让方华润双鹤已足额缴纳了30%缔约保证金。谢谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400025926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159001","BK0201","BK0186","BK0175","BK0188","BK0229","BK0122","BK0239","600062","BK0028","BK0010","002258","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659813779","title":"华润双鹤(600062.SH)子公司乳酸钠林格冲洗液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2659813779","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659813779?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:07","pubTimestamp":1786612030,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司全资子公司上海长征富民金山制药有限公司收到了国家药品监督管理局颁发的乳酸钠林格冲洗液《药品注册证书》。该药品适用于允许使用无菌电解质溶液的一般冲洗。此次获得《药品注册证书》视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0188","BK0175","BK0010","BK0185","600062","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901489","title":"股市必读：华润双鹤新发布《华润双鹤关于控股子公司河南中帅医药科技有限责任公司乙酰唑胺缓释胶囊获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901489","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659901489?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:06","pubTimestamp":1786554373,"startTime":"0","endTime":"0","summary":"公司公告汇总华润双鹤关于控股子公司河南中帅医药科技有限责任公司乙酰唑胺缓释胶囊获得药品注册证书的公告华润双鹤控股子公司中帅医药研发的乙酰唑胺缓释胶囊获得国家药监局颁发的《药品注册证书》，规格为0.5g，注册分类为化学药品3类，视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300000895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0010","BK0175","BK1574","159938","600062","BK1515","BK0028","BK0188","09939","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903206","title":"华润双鹤（600062）披露全资子公司DC7001A胶囊获临床试验批准通知书，8月12日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903206","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658903206?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:17","pubTimestamp":1786544236,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，华润双鹤报收于16.39元，较前一交易日上涨0.06%，最新总市值为170.22亿元。该股当日开盘16.41元，最高16.58元，最低16.28元，成交额达1.39亿元，换手率为0.82%。近日，华润双鹤发布关于全资子公司北京双鹤润创科技有限公司DC7001A胶囊获得药物临床试验批准通知书的公告。公告显示，该公司收到国家药品监督管理局签发的DC7001A胶囊《药物临床试验批准通知书》，同意开展临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200040119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0175","BK0188","600062","BK0239","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658238996","title":"华润双鹤(600062.SH)子公司乙酰唑胺缓释胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2658238996","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658238996?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:34","pubTimestamp":1786440891,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司河南中帅医药科技有限责任公司收到了国家药品监督管理局颁发的乙酰唑胺缓释胶囊《药品注册证书》。该药品为国内首款获批预防或改善急性高山病的药品。此次获得《药品注册证书》视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华润双鹤(600062.SH)子公司乙酰唑胺缓释胶囊获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0175","BK0185","600062","BK0010","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960234","title":"华润双鹤：本次并购资金来源于公司自有资金及自筹资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658960234?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:33","pubTimestamp":1786433604,"startTime":"0","endTime":"0","summary":"本次并购资金来源于公司自有资金及自筹资金。公司自有资金充足，近年来经营性现金流持续稳健向好。从财务状况来看，公司与利尔化学资产负债率处于较低水平，财务结构稳健，且公司拥有广泛的战略合作银行资源及债券融资经验，融资空间充足，可充分保障本次交易的资金足额、及时到位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK0188","BK0175","600062","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658602319","title":"华润双鹤：利尔化学为细分领域行业龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2658602319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658602319?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:33","pubTimestamp":1786433602,"startTime":"0","endTime":"0","summary":"投资者提问：请问公司以30块的股价收购利尔化学，都超过利尔化学历史最高价，比同行农药公司估值高两倍，公司怎么实现国有资产保值增值？利尔化学为细分领域行业龙头，具备成熟产销体系、万吨级生产基地及合成生物相关布局，战略价值突出，可承接公司合成生物管线落地，助力公司打通技术产业化商业闭环，加速合成生物第二增长曲线落地。目前利尔化学处于业绩回升阶段，估值尚有较大提升空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002258","BK0175","600062","BK0229","BK0010","BK0239","BK0188","BK0201","BK0186","BK0028","BK0122","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670221","title":"股市必读：华润双鹤新发布《华润双鹤关于全资子公司华润双鹤利民药业(济南)有限公司普瑞巴林缓释片完成Ⅲ期临床试验的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670221","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670221?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:41","pubTimestamp":1786297268,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，华润双鹤报收于16.36元，上涨2.25%，换手率1.25%，成交量12.94万手，成交额2.09亿元。公司公告汇总华润双鹤关于全资子公司华润双鹤利民药业(济南)有限公司普瑞巴林缓释片完成Ⅲ期临床试验的公告华润双鹤全资子公司双鹤利民的普瑞巴林缓释片已完成Ⅲ期临床试验登记公示。该试验为随机、双盲、安慰剂对照、多中心临床试验，旨在评价其治疗带状疱疹后神经痛的有效性和安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0185","BK0010","600062","BK0028","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673097","title":"每周股票复盘：华润双鹤（600062）多款药品拟中选集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673097","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673097?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:12","pubTimestamp":1786212731,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，华润双鹤报收于16.36元，较上周的16.27元上涨0.55%。本周，华润双鹤8月4日盘中最高价报16.54元。本周关注点来自公司公告汇总：华润双鹤多个产品拟中选第十二批全国药品集中采购，采购周期至2029年12月31日。华润双鹤全资子公司华润双鹤利民药业(济南)有限公司的普瑞巴林缓释片已完成Ⅲ期临床试验登记公示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0188","BK0010","600062","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689998","title":"华润双鹤(600062.SH)子公司普瑞巴林缓释片完成Ⅲ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689998","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657689998?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:09","pubTimestamp":1786007354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润双鹤 发布公告，近日，公司全资子公司华润双鹤利民药业(济南)有限公司普瑞巴林缓释片完成Ⅲ期临床试验登记公示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","600062","BK0028","BK0188","BK0010","BK0185","PSYK","IBBJ","MDTX","BK0175","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657152196","title":"股市必读：华润双鹤新发布《华润双鹤关于合作方回购八氟丙烷脂质微球注射液相关权益的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657152196","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657152196?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:34","pubTimestamp":1785951252,"startTime":"0","endTime":"0","summary":"公司公告汇总：华润双鹤已收到兰索斯支付的首期回购款1,500万美元，对应八氟丙烷脂质微球注射液中国权益回购事项。公司公告汇总华润双鹤关于合作方回购八氟丙烷脂质微球注射液相关权益的公告华润双鹤药业股份有限公司于2026年6月16日与美国兰索斯医学成像公司签署《回购协议》，由兰索斯以总价3,000万美元回购八氟丙烷脂质微球注射液在中国境内的所有权益，并终止双方此前签订的合作协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0239","BK0185","BK0010","BK0028","600062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552185","title":"华润双鹤（600062）披露合作方回购八氟丙烷脂质微球注射液相关权益的公告，8月4日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552185","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656552185?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:24","pubTimestamp":1785853465,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，华润双鹤报收于16.3元，较前一交易日下跌0.06%，最新总市值为169.29亿元。近日，华润双鹤药业股份有限公司披露《关于合作方回购八氟丙烷脂质微球注射液相关权益的公告》。公告显示，公司于2026年6月16日与美国兰索斯医学成像公司签署《回购协议》，由兰索斯以总价3,000万美元回购八氟丙烷脂质微球注射液在中国境内的所有权益，并终止双方此前签订的合作协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0185","600062","BK0175","BK0010","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656026589","title":"56.56亿元“A吃A”背后：华润双鹤营收滞涨，利尔化学业绩“过山车”，双重波动下“第二曲线”待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2656026589","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656026589?lang=zh_cn&edition=full","pubTime":"2026-08-04 11:27","pubTimestamp":1785814077,"startTime":"0","endTime":"0","summary":"华润双鹤胜出，56.56亿元拿下利尔化学实控权重大资产购买预案显示，华润双鹤拟以支付现金的方式向久远集团购买其持有的利尔化学 20%股份、向化材科技购买其持有的利尔化学3.5%股份。交易完成后，利尔化学控股股东将由久远集团变更为华润双鹤，实际控制人变更为中国华润。截至2026年一季度末，华润双鹤商誉已达10.77亿元，利尔化学并表后将进一步推高商誉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026080400015704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600062","002258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327945","title":"华润双鹤(600062.SH)部分药品拟中选全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327945","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327945?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:45","pubTimestamp":1785750355,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润双鹤(600062.SH)发布公告，2026年7月31日，公司及部分下属子公司参加了联合采购办公室组织的第十二批全国药品集中采购竞标，公司包括氨氯地平贝那普利口服常释剂型等部分产品拟中选本次集中采购。本次药品集中采购是第十二批国家药品集中采购，采购周期中，医疗机构将优先使用本次药品集中采购中选药品，并确保完成约定采购量。本次拟中选产品确定中选、签订购销合同并实施，将有利于提高产品市场占有率，提升公司的品牌影响力，对公司未来的经营业绩产生积极的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600062","BK0010","BK0188","BK0175","BK0185","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656348623","title":"股市必读：华润双鹤（600062）7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656348623","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656348623?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:00","pubTimestamp":1785690047,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，华润双鹤报收于16.27元，上涨0.25%，换手率1.29%，成交量13.37万手，成交额2.16亿元。董秘最新回复投资者： 董秘你好，请问公司什么时间分红？公司于2026年7月22日披露《2025年年度权益分派实施公告》，本次现金红利发放日为2026年7月28日。具体情况详见上海证券交易所网站。当日关注点交易信息汇总：7月31日主力资金净流出2238.37万元，占总成交额10.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK0028","BK0185","BK0175","BK0188","600062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656522316","title":"每周股票复盘：华润双鹤（600062）拟56.56亿控股利尔化学","url":"https://stock-news.laohu8.com/highlight/detail?id=2656522316","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656522316?lang=zh_cn&edition=full","pubTime":"2026-08-02 01:39","pubTimestamp":1785605950,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，华润双鹤报收于16.27元，较上周的16.63元下跌2.16%。本周，华润双鹤7月29日盘中最高价报16.99元。公司公告汇总华润双鹤于2026年7月29日召开第十届董事会第二十二次会议，审议通过关于公司符合重大资产重组条件的议案。华润双鹤拟以现金方式收购利尔化学23.50%股份，交易总价约56.56亿元。交易完成后，华润双鹤将成为利尔化学控股股东，实际控制人变更为中国华润有限公司。本次重组信息首次披露日为2026年7月16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK0188","BK0122","BK0201","600062","002258","BK0028","BK0175","BK0185","BK0186","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655526893","title":"华润双鹤：本次现金红利发放日为2026年7月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2655526893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655526893?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:54","pubTimestamp":1785491649,"startTime":"0","endTime":"0","summary":"证券之星消息，华润双鹤(600062)07月31日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问公司什么时间分红？华润双鹤回复：感谢您对公司的关注！公司于2026年7月22日披露《2025年年度权益分派实施公告》，本次现金红利发放日为2026年7月28日。具体情况详见上海证券交易所网站。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100030421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600062","BK0010","BK0239","BK0188","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655337504","title":"华润双鹤拟现金收购利尔化学23.5%股权 补齐合成生物产业化版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2655337504","media":"中国财富通","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655337504?lang=zh_cn&edition=full","pubTime":"2026-07-31 14:30","pubTimestamp":1785479400,"startTime":"0","endTime":"0","summary":"7月29日晚间，华润双鹤发布重大资产购买预案公告，公司拟以现金收购四川久远投资控股集团有限公司、四川化材科技有限公司合计持有的利尔化学23.5%股份。交易落地后，华润双鹤将成为利尔化学控股股东，中国华润取得利尔化学实际控制权。公告显示，本次交易合计收购利尔化学1.88亿股，对应久远集团20%股权、化材科技3.5%股权。交易顺利落地后，华润双鹤将打通国内市场与海外全球化渠道，搭建医药、农兽药双赛道生物制造产业矩阵。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=K6gyT79dUjg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0185","BK0239","BK0201","BK0186","BK0175","BK0229","002258","BK0188","BK0122","600062","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655347820","title":"华润双鹤（600062）披露拟收购利尔化学23.50%股份事项，7月30日股价下跌3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655347820","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655347820?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:47","pubTimestamp":1785404866,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，华润双鹤报收于16.23元，较前一交易日下跌3.91%，最新总市值为168.56亿元。华润双鹤于近日披露《关于暂不召开股东会审议本次重大资产购买事项的公告》。公告显示，公司拟以支付现金方式购买久远集团、四川化材科技有限公司合计持有的利尔化学188,102,749股股份，占总股本的23.50%。本次交易完成后，利尔化学控股股东将变更为华润双鹤，实际控制人变更为中国华润有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000027946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0028","BK0185","002258","600062","BK0201","BK0186","BK0239","BK0122","BK0188","BK0175","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655824355","title":"华润双鹤入主 利尔化学午收涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2655824355","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655824355?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:32","pubTimestamp":1785400320,"startTime":"0","endTime":"0","summary":"消息面上，前一日晚间，利尔化学、华润双鹤发布公告称，华润双鹤拟以支付现金的方式向四川久远投资控股集团有限公司、四川化材科技有限公司购买其合计持有的利尔化学23.5%股份。本次权益变动后，华润双鹤直接持有利尔化学1.88亿股股份，占上市公司总股本的23.5%。利尔化学控股股东将由久远集团变更为华润双鹤，利尔化学的实际控制人将变更为中国华润。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2026/07/30/5746910752367780264.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/07/30/5746910752367780264.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1785394586129569.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1785394586129569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0201","600062","BK0010","BK0188","002258","BK0175","BK0185","BK0122","BK0028","BK0239","BK0186","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786714161001,"stockEarnings":[{"period":"1week","weight":0.0263},{"period":"1month","weight":-0.0036},{"period":"3month","weight":-0.0444},{"period":"6month","weight":-0.0825},{"period":"1year","weight":-0.1673},{"period":"ytd","weight":-0.0815}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润双鹤药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"54972人(较上一季度增加0.62%)","perCapita":"18886股","listingDate":"1997-05-22","address":"北京市朝阳区望京利泽东二路1号","registeredCapital":"103858万元","survey":" 华润双鹤药业股份有限公司的主营业务是慢病业务、专科业务、输液业务、原料药业务。公司的主要产品是缬沙坦、氨氯地平、普瑞巴林、氨苯蝶啶、喷他佐辛、匹伐他汀、素钠、依诺肝素原料、辅酶Q10、S-Na盐。0号、压氏达、穗悦、贝奇灵、糖适平、卜可、冠爽、珂立苏、诺百益、小儿复方氨基酸注射液(19AA-I)、基础输液、BFS等产品获评中国化学制药行业各细分领域优秀产品品牌。","listedPrice":6.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润双鹤(600062)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润双鹤(600062)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润双鹤,600062,华润双鹤股票,华润双鹤股票老虎,华润双鹤股票老虎国际,华润双鹤行情,华润双鹤股票行情,华润双鹤股价,华润双鹤股市,华润双鹤股票价格,华润双鹤股票交易,华润双鹤股票购买,华润双鹤股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润双鹤(600062)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润双鹤(600062)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}